United States News All stories

Options market positioning suggests traders are increasingly confident bitcoin could revisit the $100,000 level.

The US Senate has confirmed investigative journalist Sara Carter as Drug Czar, marking a historic first for the role.

Morgan Stanley is seeking approval to launch Bitcoin and Solana ETFs as institutional interest in crypto investments grows.

US community banks want lawmakers to close a GENIUS Act loophole they say allows stablecoins to undercut lenders.

Brian Quintenz has joined SUI Group’s board, adding regulatory experience to the firm’s crypto treasury strategy.

Jupiter introduces JupUSD, a new Solana-native stablecoin backed by BlackRock-linked reserves.

Canaan is piloting a project that uses Bitcoin mining heat to support greenhouse farming in Canada.

Israel deepens ties with Somaliland as its foreign minister makes a historic visit following recognition.

Britain and France say troops could be sent to Ukraine after a peace deal to help deter future Russian aggression.

Mark Carney says Canada’s low-risk oil sector can withstand potential competition from increased Venezuelan production.

The US confirms it is weighing options to acquire Greenland, prompting concern across Europe and Nato.

Europe faces rising uncertainty as Trump’s Greenland ambitions test Nato unity and expose EU vulnerabilities.

China faces growing uncertainty in South America after Trump’s dramatic intervention in Venezuela reshaped regional power dynamics.

Pro-crypto Senator Cynthia Lummis criticises reported Bitcoin sales by the US government despite plans for a strategic reserve.

US carmakers report their best sales performance in years as Trump-era trade and industry policies defy earlier forecasts.

A new US bill seeks to bar politicians and federal staff from trading prediction market contracts tied to policy and politics.

Ascentage Pharma (NASDAQ:AAPG) shares were in focus on Tuesday, January 6, 2026, following the announcement that the U.S. FDA has cleared its Investigational New Drug (IND) application for APG-3288.

8x8 (NASDAQ:EGHT), a global leader in integrated cloud communications, announced on Tuesday, January 6, 2026, that it has acquired Maven Lab, a Singapore-based specialist in mobile marketing and enterprise messaging.

The acquisition is a strategic "step-change" for 8x8, designed to cement its leadership in the high-growth Asia-Pacific (APAC) customer engagement market.

By integrating Maven Lab’s team and its acclaimed Moobidesk platform into the 8x8 Platform for CX, the company is pivoting from traditional messaging toward "orchestrated, omnichannel customer journeys."

Moobidesk offers a unified interface for SMS, WhatsApp, Viber, LINE, and voice, featuring smart AI routing and automated response suggestions that have been shown to increase sales leads by an average of 10% for its enterprise clients.

The move comes as the CPaaS (Communications Platform as a Service) market is projected to grow from $32 billion today to nearly $100 billion by 2030.

With Maven Lab’s deep local carrier relationships and regional expertise, 8x8 is now uniquely positioned to support mission-critical, high-volume communications for the finance, healthcare, and logistics sectors across Southeast Asia.

HUTCHMED (China) Limited (NASDAQ:HCM) shares climbed in after-hours trading Wednesday after the company announced that its novel Syk inhibitor, sovleplenib, met the primary endpoint in the Phase III registration portion of the ESLIM-02 trial.

Baidu (NASDAQ:BIDU) announced on Wednesday, January 7, 2026, that its autonomous ride-hailing platform, Apollo Go, has received Dubai’s first-ever permit for fully driverless vehicle trials on public roads.

Caracas and Washington have agreed to send up to $2 billion worth of Venezuelan crude to U.S. refineries, a move that could reroute supply away from China.

Marvell Technology said on Tuesday it will buy networking equipment provider XConn Technologies in a deal worth ​about $540 million, as the chipmaker doubles down on data center hardware ‌amid a race to expand artificial intelligence infrastructure.

Ford Motor Company (NYSE:F) reported robust U.S. sales results for the fourth quarter and full year 2025, with Q4 sales rising 2.7% year-over-year and annual sales climbing 6% to approximately 2.2 million vehicles.

Johnson & Johnson (NYSE:JNJ) announced on Tuesday, January 6, 2026, that its Phase 2b JASMINE study of nipocalimab in adults with moderate-to-severe systemic lupus erythematosus (SLE) met its primary and key secondary endpoints.